COMP <GO>
BA vs TMO // DIVIDEND YIELD & FCF PAYOUT SAFETY
Boeing Company (The) (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: BA 3
— TMO 10
■ METRIC PARITY
LAST: $171.55 (-0.64%) • MKT CAP: $136.82B
dividend-safety
0.24%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
dividend-safety
0.24%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BA VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BA | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 4.80% | 41.00% | -36.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.40% | 9.30% | -3.90 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 28.6x | 30.4x | -1.80 | BA | /valuation <GO> |
| Free Cash Flow Yield | -1.37% | 2.40% | -3.77 | TMO | /fcf-yield <GO> |
| Operating Margin | 4.80% | 17.40% | -12.60 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.50% | 15.10% | -12.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 34.50% | 3.90% | +30.60 | BA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.24% | 0.24% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.41 | 4.50 | -3.09 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.70% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.3 | 59.1 | -26.82 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.94 | +0.01 | BA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 51.4x | 36.3x | +15.10 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $136.82B | $262.22B | -$125.40B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BA REV | TMO REV | BA GROSS % | TMO GROSS % | BA FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $89.46B | $44.56B | 4.8% | 44.0% | -$1.88B | $6.29B |
| FY 2024 | $66.52B | $42.88B | -3.0% | 44.0% | -$14.31B | $7.27B |
| FY 2023 | $77.79B | $42.86B | 44.0% | 44.0% | $2.46B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BA // BETA 0.95
TMO // BETA 0.94